行情

AEMD

AEMD

Aethlon Med
NASDAQ

实时行情|Nasdaq Last Sale

3.970
+1.570
+65.42%
盘后: 4.110 +0.14 +3.53% 19:58 01/27 EST
开盘
2.700
昨收
2.400
最高
4.070
最低
2.510
成交量
1,407.81万
成交额
--
52周最高
21.30
52周最低
0.7640
市值
2,602.72万
市盈率(TTM)
-0.0449
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AEMD 新闻

  • Acceleron肺高压药物试验达到主要目标 股价暴涨79%
  • 新浪财经.1小时前
  • 英国超市巨头承诺投10亿英镑 到2040年实现零排放
  • 新浪财经.1小时前
  • 韩国政府:将全力以赴抗击疫情并稳定金融市场
  • 新浪财经.1小时前
  • 美国父母的儿童早教支出每年高达420亿美元
  • 新浪财经.2小时前

更多

所属板块

先进医疗设备和技术
-1.95%
医疗设备和用品
-1.02%

热门股票

名称
价格
涨跌幅

AEMD 简况

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
展开

Webull提供Aethlon Medical, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。